Global Blood Therapeutics Inc (GBT)
Delisted
5 Oct 2022
NASDAQ (NGS) NASDAQ (NGS) Primary $
68. 49
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 68.49
Previous Close Investors:
Day Range
68.49 68.49
Year Range
21.65 73.02
Want to track GBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
GBT Chart
Global Blood Therapeutics Inc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JM John Malone Amundi | 4,172 | $146 | $146 | - | - |
Global Blood Therapeutics Inc (GBT) FAQ
What does "Delisted" mean?
Global Blood Therapeutics Inc has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
No dividend payments were recorded prior to delisting.
How long did the company pay dividends?
The company did not have a dividend payment history.
Were there any stock splits?
No stock splits were recorded prior to delisting.
What was the last known trading price?
The stock last traded at $68.49 on Oct 05, 2022 before being delisted.
